# Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

> **NCT00598832** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 1075 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene lotion 0.1%
- **DRUG:** Adapalene Lotion Vehicle

## Key facts

- **NCT ID:** NCT00598832
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 1075 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598832, "Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00598832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*